Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Kagabu · SciRah

Researcher profile · Semantic Scholar

M. Kagabu

Share profile

M. Kagabu — researcher profile on SciRah

h-index: 15
Works: 90
Citations: 668

Most-cited papers

Immunotherapy for Uterine Cervical Cancer Using Checkpoint Inhibitors: Future Directions
M. Kagabu, T. Nagasawa, Chie Sato, Yasuko Fukagawa +5 more
2020International Journal of Molecular Sciences77 citations Open access
Semantic Scholar
Local endothelial complement activation reverses endothelial quiescence, enabling t-cell homing, and tumor control during t-cell immunotherapy
A. Facciabene, Francesco De Sanctis, S. Pierini, E. Reis +11 more
2017Oncoimmunology65 citations Open access
Semantic Scholar
Immunotherapy for Uterine Cervical Cancer
M. Kagabu, T. Nagasawa, Daisuke Fukagawa, Hidetoshi Tomabechi +3 more
2019Healthcare40 citations Open access
Semantic Scholar
Neoadjuvant chemotherapy using platinum- and taxane-based regimens for bulky stage Ib2 to IIb non-squamous cell carcinoma of the uterine cervix
T. Shoji, E. Takatori, Tatsunori Saito, H. Omi +4 more
2012Cancer Chemotherapy and Pharmacology36 citations Open access
Semantic Scholar
Phase II basket trial of perifosine monotherapy for recurrent gynecologic cancer with or without PIK3CA mutations
K. Hasegawa, M. Kagabu, M. Mizuno, K. Oda +11 more
2017Investigational new drugs32 citations
Semantic Scholar
Sentinel node navigation surgery in cervical cancer: a systematic review and metaanalysis
T. Chiyoda, K. Yoshihara, M. Kagabu, S. Nagase +8 more
2022International Journal of Clinical Oncology28 citations
Semantic Scholar
Analysis of prognostic factors for patients with bulky squamous cell carcinoma of the uterine cervix who underwent neoadjuvant chemotherapy followed by radical hysterectomy
E. Takatori, T. Shoji, H. Omi, M. Kagabu +6 more
2015International Journal of Clinical Oncology25 citations
Semantic Scholar
Antibody-Drug Conjugates: The New Treatment Approaches for Ovarian Cancer
Sho Sato, T. Shoji, Ami Jo, Haruka Otsuka +8 more
2024Cancers19 citations Open access
Semantic Scholar
Clinical and reproductive outcomes of fertility-sparing surgery in stage I epithelial ovarian cancer
Takafumi Watanabe, S. Soeda, Hiroshi Nishiyama, Y. Kiko +15 more
2019Molecular and clinical oncology19 citations Open access
Semantic Scholar
SLFN11 is a BRCA independent biomarker for the response to platinum-based chemotherapy in high-grade serous ovarian cancer and clear cell ovarian carcinoma.
Hidehiko Akashi, N. Yachida, Haruka Ueda, Manako Yamaguchi +15 more
2023Molecular Cancer Therapeutics18 citations
Semantic Scholar
The efficacy of a third-generation oncolytic herpes simplex viral therapy for an HPV-related uterine cervical cancer model
M. Kagabu, N. Yoshino, Tatsunori Saito, Y. Miura +5 more
2020International Journal of Clinical Oncology18 citations
Semantic Scholar
Phase II clinical study of neoadjuvant chemotherapy with CDDP/CPT-11 regimen in combination with radical hysterectomy for cervical cancer with a bulky mass
T. Shoji, E. Takatori, Y. Furutake, A. Takada +10 more
2016International Journal of Clinical Oncology18 citations Open access
Semantic Scholar
Phase II study of tri-weekly cisplatin and irinotecan as neoadjuvant chemotherapy for locally advanced cervical cancer.
T. Shoji, E. Takatori, S. Hatayama, H. Omi +7 more
2010Oncology Letters17 citations Open access
Semantic Scholar
Ofranergene Obadenovec (Ofra-Vec, VB-111) With Weekly Paclitaxel for Platinum-Resistant Ovarian Cancer: Randomized Controlled Phase III Trial (OVAL Study/GOG 3018)
R. Arend, Bradley J. Monk, R. Shapira-Frommer, Ashley F. Haggerty +87 more
2023Journal of Clinical Oncology15 citations Open access
Semantic Scholar
Anti-cancer immunotherapy using cancer-derived multiple epitope-peptides cocktail vaccination clinical studies in patients with refractory/persistent disease of uterine cervical cancer and ovarian cancer [phase 2]
S. Takeuchi, M. Kagabu, T. Shoji, Yukari Nitta +3 more
2020Oncoimmunology15 citations Open access
Semantic Scholar
A New Therapeutic Strategy for Recurrent Ovarian Cancer―Bevacizumab beyond Progressive Disease
T. Shoji, Hisashi Eto, Takanori Sato, Rikako Soma +7 more
2019Healthcare15 citations Open access
Semantic Scholar
Mast cells partially contribute to mucosal adjuvanticity of surfactin in mice
N. Yoshino, Ryosuke Takeshita, Hanae Kawamura, Yutaka Sasaki +4 more
2017Immunity, Inflammation and Disease14 citations Open access
Semantic Scholar
Gemcitabine and docetaxel in a patient with primary ovarian leiomyosarcoma: a case report and review of literature
Y. Furutake, Tomoyuki Fukagawa, Yasuko Suga, T. Nagasawa +9 more
2017International Cancer Conference Journal12 citations Open access
Semantic Scholar
Paclitaxel–carboplatin for advanced or recurrent carcinosarcoma of the uterus: the Japan Uterine Sarcoma Group and Tohoku Gynecologic Cancer Unit Study
T. Takano, Takeo Otsuki, H. Tokunaga, M. Toyoshima +23 more
2014International Journal of Clinical Oncology12 citations
Semantic Scholar
Efficacy and Safety of Platinum Rechallenge in Patients With Platinum-resistant Ovarian, Fallopian Tube or Primary Peritoneal Cancer: A Multicenter Retrospective Study
Shunsuke Tatsuki, T. Shoji, Marina Abe, Hidetoshi Tomabechi +6 more
2022Anticancer Research11 citations Open access
Semantic Scholar
Novel Therapeutic Strategies for Refractory Ovarian Cancers: Clear Cell and Mucinous Carcinomas
T. Shoji, Shunsuke Tatsuki, Marina Abe, Hidetoshi Tomabechi +6 more
2021Cancers11 citations Open access
Semantic Scholar
A randomized phase II/III trial of conventional paclitaxel and carboplatin with or without bevacizumab versus dose-dense paclitaxel and carboplatin with or without bevacizumab, in stage IVB, recurrent, or persistent cervical carcinoma (JCOG1311): Primary analysis.
M. Ishikawa, T. Shibata, T. Iwata, S. Nishio +10 more
2021Gynecologic Oncology11 citations Open access
Semantic Scholar
Treatment of HPV-Related Uterine Cervical Cancer with a Third-Generation Oncolytic Herpes Simplex Virus in Combination with an Immune Checkpoint Inhibitor
M. Kagabu, N. Yoshino, Kazuyuki Murakami, H. Kawamura +3 more
2023International Journal of Molecular Sciences10 citations Open access
Semantic Scholar
Immunosuppressive tumor microenvironment in Uterine Serous Carcinoma via CCL7 signal with myeloid-derived suppressor cells.
Yuka Mise, J. Hamanishi, T. Daikoku, S. Takamatsu +18 more
2022Carcinogenesis10 citations Open access
Semantic Scholar
Efficacy and Safety of Platinum-based Chemotherapy With Bevacizumab Followed by Bevacizumab Maintenance for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer During PARP Inhibitor Therapy: A Multicenter Retrospective Study
Marina Abe, T. Shoji, Y. Chiba, E. Takatori +6 more
2023Anticancer Research9 citations Open access
Semantic Scholar
Critical micelle concentration and particle size determine adjuvanticity of cyclic lipopeptides
N. Yoshino, Ryosuke Takeshita, Hanae Kawamura, Kazuyuki Murakami +7 more
2018Scandinavian Journal of Immunology8 citations
Semantic Scholar
Clinical efficacy of nedaplatin-based concurrent chemoradiotherapy for uterine cervical cancer: a Tohoku Gynecologic Cancer Unit Study
M. Kagabu, T. Shoji, Kazuyuki Murakami, H. Omi +16 more
2016International Journal of Clinical Oncology8 citations
Semantic Scholar
Expectations and Challenges of First-Line Maintenance Therapy for Advanced Ovarian Cancer
T. Shoji, Chie Sato, Hidetoshi Tomabechi, E. Takatori +4 more
2021Medicina7 citations Open access
Semantic Scholar
Acute Coronary Syndrome Associated with Oral Administration of Ritodrine Hydrochloride during Pregnancy: A Case Report
M. Kagabu, Shinya Murai, T. Ogasawara
2001The journal of obstetrics and gynaecology research7 citations
Semantic Scholar
Comparison of Treatment Outcomes Between First-Line Chemotherapy With or Without Bevacizumab for Advanced Ovarian Clear Cell Carcinoma (Tohoku Gynecologic Cancer Unit: TGCU-RS001A Study)
T. Shoji, E. Takatori, T. Nagasawa, M. Kagabu +17 more
2024Cancers6 citations Open access
Semantic Scholar
A phase II study of irinotecan and pegylated liposomal doxorubicin in platinum-resistant recurrent ovarian cancer (Tohoku Gynecologic Cancer Unit 104 study)
T. Shoji, E. Takatori, H. Omi, M. Kagabu +15 more
2017Cancer Chemotherapy and Pharmacology6 citations Open access
Semantic Scholar
A pilot study of oxaliplatin with oral S-1 as second-line chemotherapy for patients with recurrent adenocarcimona of the uterine cervix
E. Takatori, T. Shoji, Yasuko Suga, H. Niinuma +6 more
2014International Journal of Clinical Oncology6 citations
Semantic Scholar
Pilot Study of Intraperitoneal Administration of Triamcinolone Acetonide for Cancerous Ascites in Patients With End-Stage Gynecological Cancer
T. Shoji, E. Takatori, Y. Miura, A. Takada +6 more
2014International Journal of Gynecologic Cancer6 citations Open access
Semantic Scholar
Treatment strategies for advanced and recurrent endometrial cancer using immune checkpoint inhibitors
Ami Jo, T. Shoji, Haruka Otsuka, Marina Abe +8 more
2025International Journal of Clinical Oncology5 citations
Semantic Scholar
A single-institution retrospective exploratory analysis on the effectiveness and safety of lenvatinib plus pembrolizumab for advanced endometrial cancer: insights from ProMisE molecular classification system.
Yohei Chiba, M. Kagabu, M. Osakabe, Rikako Ito +7 more
2024Japanese Journal of Clinical Oncology5 citations
Semantic Scholar
Comparison of Postoperative Adjuvant Chemotherapy and Concurrent Chemoradiotherapy for FIGO2018 Stage IIIC1 Cervical Cancer: A Retrospective Study
M. Kagabu, T. Nagasawa, Shunsuke Tatsuki, Yasuko Fukagawa +5 more
2021Medicina5 citations Open access
Semantic Scholar
Cytokine dynamics and quality of life: unraveling the impact of cell-free and concentrated ascites reinfusion therapy in ovarian cancer patients
Rikako Ito, M. Kagabu, Sho Sato, E. Takatori +6 more
2025International Journal of Clinical Oncology4 citations Open access
Semantic Scholar
Prevalence of germline BRCA1/2 pathogenic variants in Japanese patients treated with castration-resistant prostate cancer and efficacy of CRPC treatment in real-world clinical practice.
S. Maekawa, Ryo Takata, Kie Sekiguchi, M. Kagabu +12 more
2023Japanese Journal of Clinical Oncology4 citations
Semantic Scholar
Comparison of treatment outcomes between first-line chemotherapy with or without bevacizumab for advanced ovarian, fallopian tube, and primary peritoneal cancer (Tohoku gynecologic cancer unit: TGCU-RS001 study)
T. Shoji, E. Takatori, T. Nagasawa, M. Kagabu +17 more
2022International Journal of Clinical Oncology4 citations
Semantic Scholar
Phase 2 studies of multiple peptides cocktail vaccine for treatment-resistant cervical and ovarian cancer.
S. Takeuchi, T. Shoji, M. Kagabu, Tatsuya Honda +4 more
20154 citations
Semantic Scholar
[Results of neoadjuvant chemotherapy using tri-weekly CDDP/CPT-11 for locally advanced cervical cancer].
T. Shoji, E. Takatori, M. Murai, S. Hatayama +10 more
2010Gan to kagaku ryoho. Cancer & chemotherapy4 citations
Semantic Scholar
Ovarian serous borderline tumors with recurrent or extraovarian lesions: a Japanese, retrospective, multi-institutional, population-based study
T. Baba, M. Koshiyama, M. Kagabu, Yoshiki Mikami +11 more
2023International Journal of Clinical Oncology3 citations Open access
Semantic Scholar
A phase II clinical trial of palonosetron for the management of delayed vomiting in gynecological cancer patients receiving paclitaxel/carboplatin therapy.
E. Takatori, T. Shoji, Y. Miura, M. Nagao +6 more
2015Molecular and clinical oncology3 citations Open access
Semantic Scholar
Neoadjuvant Chemotherapy Using Platinum-Based Regimens for Stage Ib2-II Squamous Cell Carcinoma and Non-Squamous Cell Carcinoma of the Cervix
T. Shoji, E. Takatori, H. Omi, M. Kagabu +7 more
20123 citations Open access
Semantic Scholar
A retrospective study of neoadjuvant chemotherapy plus radical hysterectomy versus radical hysterectomy alone in patients with stage II cervical squamous cell carcinoma presenting as a bulky mass
E. Takatori, T. Shoji, A. Takada, T. Nagasawa +6 more
2016OncoTargets and Therapy2 citations Open access
Semantic Scholar
A phase I/II study of multiple peptides cocktail vaccine for advanced/recurrent ovarian cancer.
S. Takeuchi, T. Shoji, M. Kagabu, Tatsuya Honda +4 more
20132 citations
Semantic Scholar
Efficacy and safety of bevacizumab-combined single-agent chemotherapy for platinum-resistant ovarian cancer that recurred during PARP inhibitor treatment
E. Takatori, T. Shoji, Ami Jo, Miku Musashi +10 more
2026International Journal of Clinical Oncology1 citations Open access
Semantic Scholar
Efficacy of Platinum-based Chemotherapy for Platinum-sensitive Recurrent Ovarian Cancer During PARP Inhibitor Treatment: A Multicenter Retrospective Study
E. Takatori, T. Shoji, Ami Jo, Miku Musashi +10 more
2025Anticancer Research1 citations
Semantic Scholar
Evaluation of platinum-free interval and chemotherapeutic effect of subsequent platinum-containing chemotherapy in patients with recurrent ovarian cancer initially treated with bevacizumab: SGSG018/Intergroup study
Tamaki Tanaka, K. Takehara, T. Usami, Masako Ishikawa +15 more
2025Gynecologic Oncology Reports1 citations Open access
Semantic Scholar
Enhanced immune checkpoint inhibitor therapy for advanced recurrent cervical cancer: the key to treatment efficacy and maintenance of quality of life
M. Kagabu, Tsukasa Baba
2024EBioMedicine1 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

T. Shoji×34
Invite
T. Shoji — researcher profile on SciRah
E. Takatori×25
Invite
E. Takatori — researcher profile on SciRah
T. Nagasawa×20
Invite
T. Nagasawa — researcher profile on SciRah
T. Sugiyama×19
Invite
T. Sugiyama — researcher profile on SciRah

×15

Invite

Tsukasa Baba — researcher profile on SciRah

Invite

H. Omi — researcher profile on SciRah

Yoshitaka Kaido×13

Invite

Yoshitaka Kaido — researcher profile on SciRah

Invite

T. Baba — researcher profile on SciRah

Fumiharu Miura×10

Invite

Fumiharu Miura — researcher profile on SciRah

S. Takeuchi×10

Invite

S. Takeuchi — researcher profile on SciRah

Tatsuya Honda×10

Invite

Tatsuya Honda — researcher profile on SciRah

Hidetoshi Tomabechi×7

Invite

Hidetoshi Tomabechi — researcher profile on SciRah